ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
21.98
+0.64 (3.00%)
At close: Jun 6, 2025, 4:00 PM
21.75
-0.23 (-1.05%)
After-hours: Jun 6, 2025, 5:06 PM EDT
ACADIA Pharmaceuticals Employees
As of December 31, 2024, ACADIA Pharmaceuticals had 654 total employees, including 653 full-time and 1 part-time employees. The number of employees increased by 56 or 9.36% compared to the previous year.
Employees
654
Change (1Y)
56
Growth (1Y)
9.36%
Revenue / Employee
$1,523,369
Profits / Employee
$349,974
Market Cap
3.68B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ACAD News
- 1 day ago - Acadia Pharmaceuticals to Host R&D Day in New York City on June 25, 2025 - Business Wire
- 8 days ago - Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire
- 10 days ago - Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise - Business Wire
- 17 days ago - Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 18 days ago - These Analysts Boost Their Forecasts On Acadia Pharmaceuticals - Benzinga
- 20 days ago - Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout Preview - Seeking Alpha
- 21 days ago - Delaware District Court Rules in Favor of Acadia in NUPLAZID® (pimavanserin) Formulation Patent Litigation - Business Wire
- 24 days ago - ACADIA Pharmaceuticals: Advancing On Several Fronts - Seeking Alpha